• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Multiple Sclerosis Treatment Devices Market

    ID: MRFR/HC/57635-CR
    161 Pages
    Rahul Gotadki
    July 2025

    Multiple Sclerosis Treatment Devices Market Research Report Information by Type (Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), Clinically Isolated Syndrome (CIS)), by Treatment Devices (Electrical Stimulation Devices (Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS)), Neurostimulation Devices (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS))), by End-User (Hospitals & Clinics, Ambulatory ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Multiple Sclerosis Treatment Devices Market Research Report – Forecast Till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Infographic

    Multiple Sclerosis Treatment Devices Market Summary

    The Global Multiple Sclerosis Treatment Devices Market is projected to grow from 0.85 USD Billion in 2024 to 1.46 USD Billion by 2035.

    Key Market Trends & Highlights

    Multiple Sclerosis Treatment Devices Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate of 5.04% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1.46 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 0.85 USD Billion, reflecting the current demand for innovative treatment devices.
    • Growing adoption of advanced therapeutic technologies due to increasing prevalence of multiple sclerosis is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.85 (USD Billion)
    2035 Market Size 1.46 (USD Billion)
    CAGR (2025-2035) 5.04%

    Major Players

    Enovis, Axonics, Inc., Koninklijke Philips N.V., BTL, Bayer AG, Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd

    Multiple Sclerosis Treatment Devices Market Trends

    The landscape of Multiple Sclerosis treatment devices is evolving, driven by advancements in technology and a growing emphasis on personalized medicine, which may enhance patient outcomes and improve quality of life.

    National Institutes of Health (NIH)

    Multiple Sclerosis Treatment Devices Market Drivers

    Rising Prevalence of Multiple Sclerosis

    The increasing incidence of multiple sclerosis (MS) globally drives the demand for innovative treatment devices. As of 2024, the Global Multiple Sclerosis Treatment Devices Market Industry is valued at 0.85 USD Billion, reflecting a growing need for effective management solutions. The World Health Organization indicates that the prevalence of MS is rising, particularly in regions with higher latitudes. This trend necessitates the development and adoption of advanced treatment devices, as healthcare providers seek to improve patient outcomes. The projected growth of the market to 1.46 USD Billion by 2035 underscores the urgency for innovative solutions in managing this chronic condition.

    Market Segment Insights

    Multiple Sclerosis Treatment Devices by Type Insights

    Based on Type, this segment includes Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), and Clinically Isolated Syndrome (CIS). The Relapsing-remitting Multiple Sclerosis (RRMS) segment dominated the global market in 2024.

    The Primary Progressive Multiple Sclerosis (PPMS) segment is projected to be the fastest-growing segment during the forecast period. This growth is attributed to increasing awareness, advancements in diagnostic techniques, and the launch of novel therapies targeting progressive forms of MS.

    As treatment options evolve, demand for targeted PPMS solutions is anticipated to rise significantly.

    FIGURE 2: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE BY TYPE 2024 AND 2035 (USD BILLION)

    Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

    Multiple Sclerosis Treatment Devices by Treatment Devices Insights

    Based on Treatment Devices, this segment includes Electrical Stimulation Devices (Functional Electrical Stimulation (FES) and Transcutaneous Electrical Nerve Stimulation (TENS)), and Neurostimulation Devices (Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS)). The Electrical Stimulation Devices segment dominated the global market in 2024.

    This segment is projected to be the fastest-growing during the forecast period. These devices enhance mobility and improve quality of life for patients, which has driven their widespread acceptance in both clinical and home care settings.

    Furthermore, this segment is projected to be the fastest-growing during the forecast period, supported by technological advancements, increased investment in neuro-rehabilitation, and rising awareness of non-pharmacological interventions.

    Compared to neurostimulation devices, electrical stimulation offers a cost-effective and accessible treatment option, contributing to its rapid growth and expanding role in MS symptom management.

    Multiple Sclerosis Treatment Devices by End-User Insights

    Based on the End-User, this segment includes Hospitals & Clinics and Ambulatory Surgical Centers. The Hospitals & Clinics segment dominated the global market in 2024.

    Hospitals and clinics serve as primary centers for diagnosis, therapy initiation, and long-term management of multiple sclerosis, driving consistent demand.

    The Ambulatory Surgical Centers (ASCs) segment is projected to be the fastest-growing during the forecast period. This growth is fueled by the rising preference for minimally invasive procedures, shorter recovery times, and reduced healthcare costs associated with ASCs.

    Increasing patient inclination toward outpatient care and advancements in portable treatment device technologies further support the rapid expansion of this segment in the coming years.

    Get more detailed insights about Multiple Sclerosis Treatment Devices Market Research Report – Forecast Till 2035

    Request Free Sample

    Regional Insights

    Based on the Region, the global Multiple Sclerosis Treatment Devices are segmented into North America, Europe, Asia-Pacific, South America and Middle East & Africa. Europe dominated the global market in 2024.

    The Asia-Pacific is projected to be the fastest-growing segment during the forecast period. Major demand factors driving the Europe market are the increasing prevalence of multiple sclerosis (MS) and advancements in neurostimulation and wearable technologies.

    Europe dominated the global Multiple Sclerosis (MS) Treatment Devices market due to its advanced healthcare infrastructure and rising prevalence of MS. The region benefits from strong investments in research and development.

    It also benefits from the growing adoption of innovative neurostimulation and wearable technologies. These advancements support more effective symptom management and improve patient quality of life, driving market growth.

    Government initiatives and increased awareness of early diagnosis and treatment options also contribute to Europe’s leading position.

    FIGURE 3: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET VALUE BY REGION 2024 AND 2035 (USD BILLION)

    MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET VALUE BY REGION 2024 AND 2035

    Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Further, the countries considered in the scope of the Application Tracking System Market are the US, Canada, Germany, France, UK, Spain, Italy, Russia, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Brazil, Mexico, Argentina, GCC Countries, South Africa and others.

    Key Players and Competitive Insights

    Many global, regional, and local vendors characterize the Multiple Sclerosis Treatment Devices Market. The market is highly competitive, with all the players competing to gain market share.

    Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth.

    The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.

    The major competitors in the market are Enovis, Axonics, Inc., Koninklijke Philips N.V., BTL, Bayer AG, Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd, among others.

    The Multiple Sclerosis Treatment Devices Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.

    Key Companies in the Multiple Sclerosis Treatment Devices Market market include

    Industry Developments

    August 2024 The FDA recently approved Medtronic’s closed-loop rechargeable spinal cord stimulator (SCS). This approval makes Inceptiv the first SCS device on the market with a closed-loop feature that continuously senses biological signals along the spinal cord and automatically adjusts stimulation in real time, ensuring therapy remains synchronized with patients' daily activities.

    April 2023 Biotronik announced that it received FDA approval for its Prospera Spinal Cord Stimulation (SCS) system, which features Resonance, a multiphase stimulation paradigm. The system is paired with Embrace One, a patient-centric care model that offers automatic, objective, daily remote monitoring.

    January 2021 Boston Scientific launched the WaveWriter Alpha Spinal Cord Stimulator (SCS) Systems in the U.S., offering a comprehensive portfolio of four MRI-conditional, Bluetooth-enabled implantable pulse generators (IPGs). Available in both rechargeable and non-rechargeable options.

    Future Outlook

    Multiple Sclerosis Treatment Devices Market Future Outlook

    The Multiple Sclerosis Treatment Devices Market is projected to grow at a 5.04% CAGR from 2024 to 2035, driven by technological advancements, increasing patient awareness, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven diagnostic tools to enhance treatment personalization.
    • Invest in portable devices for home-based therapy to improve patient compliance.
    • Explore partnerships with telehealth platforms to expand market reach and accessibility.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements in treatment technologies and increased patient engagement.

    Market Segmentation

    Multiple Sclerosis Treatment Devices by Type Outlook

    • Primary Progressive Multiple Sclerosis (PPMS)
    • Secondary Progressive Multiple Sclerosis (SPMS)
    • Relapsing-remitting Multiple Sclerosis (RRMS)
    • Clinically Isolated Syndrome (CIS)

    Multiple Sclerosis Treatment Devices Regional Outlook

    • US
    • Canada
    • Mexico

    Multiple Sclerosis Treatment Devices by End-User Outlook

    • Hospitals & Clinics
    • Ambulatory Surgical Centers

    Multiple Sclerosis Treatment Devices by Treatment Devices Outlook

    • Functional Electrical Stimulation (FES)
    • Transcutaneous Electrical Nerve Stimulation (TENS)

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 USD 0.85 Billion
    Market Size 2025 USD 0.88 Billion
    Market Size 2035 USD 1.46 Billion
    Compound Annual Growth Rate (CAGR) 5.08% (2025-2035)
    Base Year 2024
    Forecast Period 2025-2035
    Historical Data 2019-2023
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered By Type, By Treatment Devices, By End-User
    Geographies Covered North America, Europe, Asia Pacific, South America, Middle East & Africa
    Countries Covered The US, Canada, Mexico, Germany, UK, France, Russia, Italy, Spain, China, India, Japan, South Korea, Thailand, Indonesia, Brazil, Argentina, GCC Countries, South Africa
    Key Companies Profiled Enovis, Axonics, Inc., Koninklijke Philips N.V., BTL, Bayer AG, Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd
    Key Market Opportunities ·         Rising collaborations between healthcare providers and technology firms
    Key Market Dynamics ·         Increasing prevalence of multiple sclerosis (MS) ·         Advancements in neurostimulation and wearable devices

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the Multiple Sclerosis Treatment Devices Market?

    USD 0.85 Million is the Multiple Sclerosis Treatment Devices Market in 2024

    Which Type holds the largest market share?

    The Relapsing-remitting Multiple Sclerosis (RRMS) segment by Type holds the largest market share and grows at a CAGR of 5.03 % during the forecast period.

    Which region holds the largest market share in the Multiple Sclerosis Treatment Devices Market?

    Europe holds the largest market share in the Multiple Sclerosis Treatment Devices Market.

    Who are the prominent players in the Multiple Sclerosis Treatment Devices Market?

    Enovis, Axonics, Inc., Koninklijke Philips N.V., BTL, Bayer AG, Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd are prominent players in the Multiple Sclerosis Treatment Devices Market.

    Which Treatment Devices segment led the Multiple Sclerosis Treatment Devices Market?

    The Electrical Stimulation Devices segment dominated the market in 2024.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027